NCT03868540View on ClinicalTrials.gov

A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

November 25, 2019

Study Completion Date

November 25, 2019

Conditions
Healthy
Interventions
DRUG

BI 1291583

tablet

DRUG

Placebo

tablet

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY